Sector Investors News and Insights

Pfizer lags in the competition for weight loss drugs despite conducting a pill trial, according to Jared Holz from Mizuho.

Pfizer is far behind weight loss drug race despite pill trial, says Mizuho’s Jared Holz…

Read More: https://www.youtube.com/watch?v=Wm9br_O53dI

More News
Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.